Angiogenesis in Acute Myeloid Leukemia and Opportunities for Novel Therapies

Quantification of VEGF isoforms and VEGFR transcripts by qRT-PCR and their significance in acute myeloid leukemia

(2017) Samia Mourah et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS

Dynamic Contrast-enhanced MR Imaging Measurement of Vertebral Bone Marrow Perfusion May Be Indicator of Outcome of Acute Myeloid Leukemia Patients in Remission

(2011) Bang-Bin Chen et al.   RADIOLOGY

Leukemia regression by vascular disruption and antiangiogenic therapy

(2010) G. J. Madlambayan et al.   BLOOD

Monoclonal antibodies in the treatment of metastatic colorectal cancer: A review

(2010) Jolien Tol et al.   CLINICAL THERAPEUTICS

Sorafenib bei rezidivierter und therapierefraktärer FLT3-ITD-positiver akuter myeloischer Leukämie: eine neue Behandlungsoption

(2010) S Metzelder et al.   DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT

Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release

(2010) Håkon Reikvam et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Phase I/II Study of Combination Therapy With Sorafenib, Idarubicin, and Cytarabine in Younger Patients With Acute Myeloid Leukemia

(2010) Farhad Ravandi et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma

(2010) Tracy T. Batchelor et al.   JOURNAL OF CLINICAL ONCOLOGY

Aflibercept Exerts Antivascular Effects and Enhances Levels of Anthracycline Chemotherapy In vivo in Human Acute Myeloid Leukemia Models

(2010) D. Lal et al.   MOLECULAR CANCER THERAPEUTICS

Vascular Endothelial Growth Factor A isoform mRNA expression in pediatric acute myeloid leukemia

(2010) R.C. Kruizinga et al.   PEDIATRIC BLOOD & CANCER

Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial

(2009) Lorenza Rimassa et al.   Expert Review of Anticancer Therapy

Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors

(2009) A. Craig Lockhart et al.   JOURNAL OF CLINICAL ONCOLOGY

Blood cell generation from the hemangioblast

(2009) Christophe Lancrin et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Contribution of bone microenvironment to leukemogenesis and leukemia progression

(2009) F Ayala et al.   LEUKEMIA

Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survival

(2008) T. T.-F. Shih et al.   BLOOD

Blood outgrowth endothelial cells from chronic myeloid leukaemia patients are BCR/ABL1 negative

(2008) Jasmin Otten et al.   BRITISH JOURNAL OF HAEMATOLOGY

Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators

(2008) Kimberley Hatfield et al.   BRITISH JOURNAL OF HAEMATOLOGY

A phase I and pharmacokinetic study of daily oral cediranib, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer: A study of the National Cancer Institute of Canada Clinical Trials Group

(2008) Glenwood Goss et al.   EUROPEAN JOURNAL OF CANCER

A phase I trial of CEP-701 + gemcitabine in patients with advanced adenocarcinoma of the pancreas

(2008) Emily Chan et al.   INVESTIGATIONAL NEW DRUGS

Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia

(2007) Hsin-An Hou et al.   LEUKEMIA RESEARCH